The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Jefferies Initiates Greggs, Games Workshop

Thu, 28th May 2020 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

UBS RAISES BURBERRY PRICE TARGET TO 983 (959) PENCE - 'SELL'

----------

KEPLER CHEUVREUX CUTS VODAFONE PRICE TARGET TO 170 (175) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES HARGREAVES LANSDOWN TARGET TO 1380 (1225) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES EXPERIAN TARGET TO 2440 (2400) PENCE - 'EQUAL-WEIGHT'

----------

DEUTSCHE BANK CUTS BRITISH LAND CO PRICE TARGET TO 475 (550) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES M&G PRICE TARGET TO 210 (200) PENCE - 'BUY'

----------

BARCLAYS RAISES INTERMEDIATE CAPITAL TARGET TO 1520 (1470) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES CRODA INTERNATIONAL TARGET TO 4100 (3900) PENCE - 'UNDERPERFORM'

----------

FTSE 250

----------

JEFFERIES INITIATES GREGGS WITH 'BUY' - TARGET 2375 PENCE

----------

JEFFERIES INITIATES GAMES WORKSHOP GROUP WITH 'BUY' - TARGET 8500 PENCE

----------

JEFFERIES RAISES BRITVIC PRICE TARGET TO 850 (800) PENCE - 'BUY'

----------

JEFFERIES CUTS BEAZLEY PRICE TARGET TO 500 (575) PENCE - 'BUY'

----------

LIBERUM RAISES PAYPOINT PRICE TARGET TO 1000 (800) PENCE - 'BUY'

----------

DAVY RAISES TRAVIS PERKINS TO 'NEUTRAL' ('UNDERPERFORM')

----------

BARCLAYS CUTS TATE & LYLE PRICE TARGET TO 730 (800) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS PROVIDENT FINANCIAL TARGET TO 405 (510) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES HAYS TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 120 (105) P

----------

RBC CUTS PROVIDENT FINANCIAL PRICE TARGET TO 195 (210) PENCE - 'SECTOR PERFORM'

----------

OTHER MAIN MARKET AND AIM

----------

JPMORGAN CUTS DAILY MAIL PRICE TARGET TO 800 (950) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE CUTS DAILY MAIL PRICE TARGET TO 708 (757) PENCE - 'NEUTRAL'

----------

LIBERUM RAISES CLINIGEN PRICE TARGET TO 1050 (850) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
10 Oct 2019 10:50

Clinigen Inks Partnership To Sell Tumor Treatment Azedra Outside US

Clinigen Inks Partnership To Sell Tumor Treatment Azedra Outside US

Read more
3 Oct 2019 09:34

BROKER RATINGS SUMMARY: Peel Hunt Raises Flutter Entertainment To Hold

BROKER RATINGS SUMMARY: Peel Hunt Raises Flutter Entertainment To Hold

Read more
30 Sep 2019 09:55

BROKER RATINGS SUMMARY: Barclays Cuts Whitbread And Raises SSE

BROKER RATINGS SUMMARY: Barclays Cuts Whitbread And Raises SSE

Read more
19 Sep 2019 13:29

Thursday broker round-up

(Sharecast News) - Ferguson: RBC Capital Markets downgrades to underperform with a target price of 5,100p.

Read more
19 Sep 2019 10:36

Clinigen Profit Drops On One-Off Costs, Despite Strong Revenue Growth

(Alliance News) - Clinigen Group PLC said Thursday annual profit dropped sharply on higher amortisation costs on acquired intangibles and acquisition expenses, despite strong revenue the financial

Read more
12 Sep 2019 16:21

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 13 September  JD WetherspoonFull Year ResultsSthreeQ3 Enterprise Investment

Read more
16 Jul 2019 10:04

Clinigen Expects Increased Annual Profit On Strong Acquisitions

(Alliance News) - Clinigen Group PLC said Thursday it expects to see a double-digit rise in profit and revenue for its recently ended financial year, driven by contributions from the year to the a

Read more
16 May 2019 06:45

CORRECT: Clinigen Retakes Ethyol And Totect US Commercial Rights

(Correcting the headline to clarify that Clinigen already had the products in its portfolio).LONDON (Alliance News) - Clinigen Group PLC on Wednesday said it has agreed to retake the US to

Read more
15 May 2019 12:43

Clinigen to take back US rights to cancer drugs

(Sharecast News) - Aim's Clinigen Group is taking back control of two oncology drugs from US partner Cumberland Pharmaceuticals.

Read more
2 Apr 2019 10:57

Clinigen monopolises global rights for skin cancer treatment

(Sharecast News) - Clinigen now owns the global rights to Proleukin after having acquired the US rights to the treatment on Tuesday following US anti-trust clearance.

Read more
27 Feb 2019 10:23

Clinigen earnings grow following CSM and iQone acquisitions

(Sharecast News) - Specialty pharmaceuticals group Clinigen saw strong earnings and cash flow growth in the first half of its trading year following a period of transformative acquisitions.

Read more
27 Feb 2019 08:55

Clinigen Group Reports "Good" Interim Performance As Revenue Rises

LONDON (Alliance News) - Clinigen Group PLC on Wednesday described its interim performance as "good", with revenue rising 24%, but profit did fall on the prior year.For the six to

Read more
20 Feb 2019 16:10

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 21 February BAE SystemsFull Year ResultsRELXFull Year Year AmericanFull

Read more
20 Feb 2019 13:19

Wednesday broker round-up

(Sharecast News) - Ocado: Peel Hunt downgrades to hold with a target price of 110p.

Read more
13 Feb 2019 12:50

Wednesday broker round-up

(Sharecast News) - Workspace Group: Berenberg downgrades to hold with a target price of 900p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.